Nu Skin Enterprises Downgraded to Underperform at Bank of America (NUS)
Several other analysts have also recently commented on the stock. Analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a “neutral” rating to a “buy” rating in a research note on Monday, May 12th. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Nu Skin Enterprises in a research note on Wednesday, May 7th. They now have a $100.00 price target on the stock, down previously from $115.00. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. Nu Skin Enterprises presently has an average rating of “Hold” and an average price target of $109.97.
Shares of Nu Skin Enterprises (NYSE:NUS) opened at 66.51 on Friday. Nu Skin Enterprises has a 52 week low of $66.36 and a 52 week high of $140.50. The stock has a 50-day moving average of $73.35 and a 200-day moving average of $83.06. The company has a market cap of $3.921 billion and a price-to-earnings ratio of 11.18.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.11. The company had revenue of $671.10 million for the quarter, compared to the consensus estimate of $656.82 million. During the same quarter in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 24.0% on a year-over-year basis. On average, analysts predict that Nu Skin Enterprises will post $6.01 earnings per share for the current fiscal year.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.